Healthcare provider profile · identity verified

Kathleen Marie Korem Sperry, ARNP-BC

Nurse Practitioner · DAYTONA BEACH, FL · NPI 1780910109

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	375	124
Amlodipine Besylate	Amlodipine Besylate	282	96
Rosuvastatin Calcium	Rosuvastatin Calcium	281	88
Gabapentin	Gabapentin	276	109
Losartan Potassium	Losartan Potassium	276	100
Prednisone	Prednisone	231	115
Lisinopril	Lisinopril	221	71
Omeprazole	Omeprazole	197	73
Albuterol Sulfate Hfa	Albuterol Sulfate	189	60
Metformin Hcl	Metformin Hcl	185	60
Metoprolol Tartrate	Metoprolol Tartrate	177	59
Furosemide	Furosemide	175	63
Levothyroxine Sodium	Levothyroxine Sodium	167	57
Buspirone Hcl	Buspirone Hcl	159	57
Nabumetone	Nabumetone	152	61
Eliquis	Apixaban	127	32
Tamsulosin Hcl	Tamsulosin Hcl	114	41
Metoprolol Succinate	Metoprolol Succinate	113	36
Carvedilol	Carvedilol	104	39
Pantoprazole Sodium	Pantoprazole Sodium	103	35
Hydrochlorothiazide	Hydrochlorothiazide	102	43
Meloxicam	Meloxicam	99	39
Trazodone Hcl	Trazodone Hcl	98	31
Azithromycin	Azithromycin	97	63
Pregabalin	Pregabalin	91	40
Mounjaro	Tirzepatide	88	16
Simvastatin	Simvastatin	82	29
Alendronate Sodium	Alendronate Sodium	81	23
Baclofen	Baclofen	81	33
Fluticasone Propionate	Fluticasone Propionate	81	32
Clonidine Hcl	Clonidine Hcl	77	26
Clopidogrel	Clopidogrel Bisulfate	70	28
Doxycycline Hyclate	Doxycycline Hyclate	70	50
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	69	43
Warfarin Sodium	Warfarin Sodium	66	suppressed
Ozempic	Semaglutide	61	12
Mirtazapine	Mirtazapine	57	28
Potassium Chloride	Potassium Chloride	57	22
Oxybutynin Chloride	Oxybutynin Chloride	54	19
Spironolactone	Spironolactone	53	15
Ciprofloxacin Hcl	Ciprofloxacin Hcl	52	43
Lovastatin	Lovastatin	51	17
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	51	43
Montelukast Sodium	Montelukast Sodium	49	15
Tramadol Hcl	Tramadol Hcl	49	35
Glimepiride	Glimepiride	47	15
Meclizine Hcl	Meclizine Hcl	46	26
Citalopram Hbr	Citalopram Hydrobromide	45	18
Dicyclomine Hcl	Dicyclomine Hcl	44	15
Duloxetine Hcl	Duloxetine Hcl	44	15
Pravastatin Sodium	Pravastatin Sodium	44	16
Ondansetron Hcl	Ondansetron Hcl	43	30
Allopurinol	Allopurinol	42	16
Bumetanide	Bumetanide	42	14
Levofloxacin	Levofloxacin	39	25
Chlorthalidone	Chlorthalidone	37	14
Fluconazole	Fluconazole	37	25
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	37	13
Tizanidine Hcl	Tizanidine Hcl	37	11
Mupirocin	Mupirocin	36	25
Symbicort	Budesonide/Formoterol Fumarate	35	13
Atenolol	Atenolol	34	11
Escitalopram Oxalate	Escitalopram Oxalate	34	11
Hydralazine Hcl	Hydralazine Hcl	34	12
Ondansetron Odt	Ondansetron	34	12
Sertraline Hcl	Sertraline Hcl	34	13
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	33	25
Enalapril Maleate	Enalapril Maleate	32	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	30	11
Tresiba Flextouch U-100	Insulin Degludec	30	suppressed
Donepezil Hcl	Donepezil Hcl	29	15
Hydroxyzine Hcl	Hydroxyzine Hcl	29	13
Nitroglycerin	Nitroglycerin	29	21
Propranolol Hcl	Propranolol Hcl	29	suppressed
Ibuprofen	Ibuprofen	28	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	28	11
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	28	suppressed
Famotidine	Famotidine	27	suppressed
Glipizide Er	Glipizide	27	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	26	suppressed
Amiodarone Hcl	Amiodarone Hcl	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	suppressed
Diclofenac Sodium	Diclofenac Sodium	24	12
Ezetimibe	Ezetimibe	24	suppressed
Myrbetriq	Mirabegron	24	suppressed
Ofloxacin	Ofloxacin	24	20
Topiramate	Topiramate	24	12
Celecoxib	Celecoxib	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	23	11
Lantus	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Belsomra	Suvorexant	22	13
Dropsafe Prep Pads	Alcohol Antiseptic Pads	22	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Amoxicillin	Amoxicillin	21	18
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Linzess	Linaclotide	21	suppressed
Arnuity Ellipta	Fluticasone Furoate	20	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Sildenafil Citrate	Sildenafil Citrate	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Glipizide	Glipizide	19	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	suppressed
Valsartan	Valsartan	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Digoxin	Digoxin	15	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	15	suppressed
Estradiol	Estradiol	15	suppressed
Jardiance	Empagliflozin	15	suppressed
Methocarbamol	Methocarbamol	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	14	11
Nystatin	Nystatin	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Ramipril	Ramipril	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Bupropion Hcl	Bupropion Hcl	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	12	suppressed
Finasteride	Finasteride	12	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Humulin R U-500 Kwikpen	Insulin Regular, Human	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	11	suppressed
Lorazepam	Lorazepam	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error